Mosaic ImmunoEngineering (CPMV) Cash from Financing Activities (2010 - 2024)
Mosaic ImmunoEngineering (CPMV) posted quarterly Cash from Financing Activities of $130000.0 for Q4 2024, up 766.67% quarter-over-quarter from $15000.0 in Q3 2024.
Mosaic ImmunoEngineering (CPMV) Cash from Financing Activities (2010 - 2024) Analysis & Trends
Mosaic ImmunoEngineering's Cash from Financing Activities history runs 9 years deep, the most recent figure standing at $130000.0 for Q4 2024.
- In Q4 2024, Cash from Financing Activities changed N/A year-over-year to $130000.0; the TTM figure through Dec 2025 stood at $145000.0 (changed 0.0% YoY), while the FY2024 annual figure was $200000.0, changed N/A from the prior year.
- Cash from Financing Activities for Q4 2024 stood at $130000.0, up from $15000.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $525003.0 in Q2 2021, with the low at $63.0 in Q3 2020.
- The 4-year median for Cash from Financing Activities is $130000.0 (2024), against an average of $202339.6.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -426.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -1.22 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 14.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -6.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 36.24 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -16.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 27.18 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -273.15 Mn |
| 10 | Mosaic ImmunoEngineering | 3.68 Mn | 3.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 130,000.00 |
| Dec 31, 2024 | 130,000.00 |
| Sep 30, 2024 | 15,000.00 |
| Sep 30, 2024 | 15,000.00 |
| Mar 31, 2022 | 341,632.00 |
| Mar 31, 2022 | 341,632.00 |
| Jun 30, 2021 | 525,003.00 |
| Jun 30, 2021 | 525,003.00 |
| Aug 31, 2020 | 63.00 |
| Aug 31, 2020 | 63.00 |
| May 31, 2014 | -137,345.00 |
| May 31, 2014 | -137,345.00 |
| Feb 28, 2014 | -44,120.00 |
| Feb 28, 2014 | -44,120.00 |
| Nov 30, 2013 | -40,009.00 |
| Nov 30, 2013 | -40,009.00 |
| May 31, 2013 | 7,500.00 |
| May 31, 2013 | 7,500.00 |
| Feb 28, 2013 | -10,080.00 |
| Feb 28, 2013 | -10,080.00 |